Asian Spectator

Men's Weekly

.

PYC'S FOURTH DRUG CANDIDATE HAS DISEASE-MODIFYING POTENTIAL IN POLYCYSTIC KIDNEY DISEASE

  • Written by PR Newswire Asia - Asian Spectator
  • PYC has developed a new drug candidate for the >5 million people worldwide[1] with Polycystic Kidney Disease (PKD)
  • This drug candidate has demonstrated efficacy in human models derived from the kidneys of patients with end-stage renal failure due to PKD[2]
  • PKD is a life-changing disease affecting 1 in every 1,000 people[3]
  • Half of the patient...

More Articles ...

  1. Ipsen and Medison Pharma Announce Health Canada Approval of Bylvay™ (odevixibat) for the treatment of pruritus due to Progressive Familial Intrahepatic Cholestasis (PFIC)

Magazine

Bagaimana tambang mineral kritis mengancam sumber air di Manggarai, NTT

● Pengelolaan mata air di Manggarai, NTT, melalui kelembagaan adat semula berjalan baik bertahun-tahun.● Tapi kini, sumber air terancam ekspansi tambang yang tumpang tindih dengan wilayah ...

Indonesia kekurangan tenaga ahli kesehatan jiwa, bisakah program Titian jadi solusinya?

● Program Titian memicu polemik karena dinilai tumpang tindih dengan standar psikolog klinis yang sudah ada.● Program ini bisa beralih menjadi pendidikan spesialis klinis yang belum ada di...

Waspadai represi digital menguat lewat RUU Disinformasi dan Propaganda Asing

Definisi propaganda dalam kamus.hermanthos● RUU Penanggulangan Disinformasi dan Propaganda Asing membuka ruang represi, meski ditujukan untuk pencegahan.● RUU ini berpotensi membuat repres...